Growth Metrics

Agilon Health (AGL) Equity Average (2021 - 2025)

Historic Equity Average for Agilon Health (AGL) over the last 5 years, with Q3 2025 value amounting to $357.5 million.

  • Agilon Health's Equity Average fell 4286.84% to $357.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $357.5 million, marking a year-over-year decrease of 4286.84%. This contributed to the annual value of $566.4 million for FY2024, which is 3348.49% down from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Equity Average is $357.5 million, which was down 4286.84% from $454.6 million recorded in Q2 2025.
  • Agilon Health's Equity Average's 5-year high stood at $1.1 billion during Q3 2021, with a 5-year trough of -$291.5 million in Q1 2021.
  • For the 5-year period, Agilon Health's Equity Average averaged around $749.6 million, with its median value being $767.1 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 47801.82% in 2022, then plummeted by 4286.84% in 2025.
  • Agilon Health's Equity Average (Quarter) stood at $1.1 billion in 2021, then fell by 4.17% to $1.1 billion in 2022, then decreased by 27.87% to $767.1 million in 2023, then crashed by 31.83% to $522.9 million in 2024, then plummeted by 31.63% to $357.5 million in 2025.
  • Its last three reported values are $357.5 million in Q3 2025, $454.6 million for Q2 2025, and $485.6 million during Q1 2025.